-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C1UNke4zNwxJ/bQQjJvlUXikNFvLcbdGtESfmfmdG9Hw8WcaXN9uHSVnjCzD2uW4 TVeKZr5wXzPeIWoby9UNHA== 0000000000-10-069686.txt : 20110104 0000000000-10-069686.hdr.sgml : 20110104 20101119190440 ACCESSION NUMBER: 0000000000-10-069686 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101119 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 PUBLIC REFERENCE ACCESSION NUMBER: 0000950123-10-025064 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-"B6UM;6U#0HQ(#`@;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED'0O26UA9V5"+TEM86=E0R]);6%G94E=(#X^+TUE9&EA0F]X M6R`P(#`@-C$R(#2]#4R]$979I8V521T(^/B]486)S+U,O4W1R M=6-T4&%R96YT)RM6FUSVS82_NX9 M_P=\)#L6@G<2G4YG$L?VI#TG:>)>>].Y#ZHL5YR3R424?6U_?7=!TB5$`L*= MDTPBF7[V!;N+?0%(7KPGWWSSXOK\S6O"OOV6O'I]3E[=G)Z\N.2$&$P5].+*-,*%(P2[4A-_>G)XS\AO]=G9[\DI'\W^3FN].3"Z`G%]?GA(R8 M\Q'S`W;&&BJ58W>$B8@P*27E24QDA(FQM!0I3)1G*T'XK*&,-E28GM\_JR6Y M7*YRE;75?94O1+9=DV5]2WZ$1_0C)=>YS);5=B1VK*(0!9729QE541^ZTU=1 M%B5E!3%*4#7P>]L\KG.3W?^ZWN4Z(]P&=%%*4FU]VC,B&&5- MQ$FBI":)21%APA4MDYB4$2:,4S8P^2Y?<)8MP9?WZY:\RLL,//JP^[3)%T7V M1RZ8)V;,C1<%M:7/+:J2#:NDRV(<<1AM:_A'WN<+F>W6>0'!=[NN]QAX$&[D M'.-P4ZU1R;M\83)R"0%0U`NO=SZ!B=77Q%A9X<4;R19F]R;G,ZGQA,[0(#7N"H0L\ M;A.=/I^>#%*%I4S";A#4P`>G"A[NUJ$.=##7H9([NFY MI*6COOMJ;O5#[DL6/VMXQ+W+UG!.+E:@G/WZ_^"9980Q'J(5K#6*PB8 MYF&[?D3/8VSO;M&@)ON(\?10[?%C/;+0#W.JR^>H+F1!%9]1G1P3JYXE5K%Y ML<)+\4^'K-'\2RQ!BK'G-CF8;\A M$(?:!69]3(GR.4IP:2F?T>%H#-IG207,G%1,T;LE;,T:LUG5KIHS\ZS$2KXEXA0*9`BK-JL4<0X02,+V'T:DH"& MRDP-E"M:'FRMSW_C.AT1%ZT"8LB$4SILME7,,J-LEB!U:/HLM<9K^P9:"?+T M_Q+*0G\I!33EY?^C@/E2"A2T."Y_5H7BR7\6NY9>/J.E8LP+3C](CH!G`J4\ M$`1%P:HGVFXR"\>*'5LJ27C$6E"'!-&&#RU1NKFD/U'*P)2D.?2_-L1[RG5N ME.3"`"^BF:+<]IW;!YQEO@ZU>I#&#@F";:$1$^R[GZLK8'^!_?-;Z#+?U%B) M7'<9:GAA:&(Z+'&ZT,BXJ^!3'M6[,TH:MENCA[W,.<^:'2[L'H>%X'@GF.O[ M/>)%$`L!97WL]S`M$3=^@#285O8@;=.UEJIK1)TJ4.FPF8>AY%_XBZ7#.@_4 M"+X=*-P7\AK=WPU`;@$P`?P*[:WL)Q@@E3PTK@I)[<%Z<+YEP8%8*U>D0I:> M^C9R"J$*@]-UFF^3L+UOQ]C.H%O?9"%Z4,P>Z'7=.:"/>><=.KB.G!4D6JZ9.PO>G'V`/3D[=-<"`5D"Q*ZY.SH"6X MF8*#ITF0C+B/#>Y86*\M?*S@UH;=5U!FP_:9>N3(4=7@'&5IP1.=XV$/_@2G M?S4EC>H=.:52TE"N>RXN%2TC!R<<&F-HBCRBH)K@YD/LM3M\VH4/-@!LU2%- MJ#(66/$][,,.,C(>97&;_1$TG\9FV:,+5M_"XD%+<+U34\^=Y0V^%H+*-"Z1 MPSP8G(:&,&Q[*].Q@W9C[$^8,-VFWV`X/';U+60CCIV;1X^YMKG_%,S3T$CY M!-OUWJ5WTC@7NEJZPT*+3Q\K=^A#FCMXSDUW[@-`=\)S5VVK^K>`)`G3&!;( M%#M(F!0/L6YBOW7:W#:D;O9@C\=0;85XM]JG=W;KQOXN)/'`Z@X6^.`6N-^L MK:+`FD5+<9:[HD[X]I4+7Z!:?N)67BS00*1/J=X M5$;.PLE87L+I6`'"R5A>PNE8"4SZ5C8_:Q(Q';73![6'1Y7]0JK MHKN3@%Y(\&X7GX48*9A@E0P+G;H[,CY)F&IU&I=(HRZ%QBN,%"Z1GE/"-&]3 M0R\)VX=>$K8/O13L$'I)V#[T4K!#Z"5A^]!+PO:A-\9VMW28OMV5%D3?@HN^ M?GS`:E&M;[>Q*ZZ^.PPJ,'6]#KL>[\!XHNO3L)WKT["=ZY.PO>O3L)WKD["] MZ].PG>O3L)WK/>S+MJU:=/%^6>_)ZPK[(?0T]E3[9A?,.P9XA*5._1T9"D2I MDJM,&K;W=Q*V]W<*=O!W$K;W=PIV\'<2MO=W$K;W=P@[]5+DW0!<4&)QB,P3 M0INA.)`%/%(EN5E!![\*N8>YNX8Q&7,4P1F**9RA1@3'8VJ,?=GB89I+?4L< M2X*T4''-`>W'8#PR?)7'PU+RTF74W[$U[QK_7?,(FZ]:;8+A5^"9CL?FC%RT MGT-XPV?P0?"4>=S+<_WY8%$4P/NQV^$I%2UP!NMHVC^U_7&WJ:E$_(+G7-II/B&_@AT#P:T%%X:MR'L*B M@[B/#6XJ(['C"F*G;QS-C2"#H:!]>TJ@[VIL_9Y>-4%SN9O,Y9:C"089-WH"OEZV[3+O#TP? MVJ=.9.\FS#:X%S3>MWJ7!E+T9O;G1$ M97-C7,I+T-R96%T;W(H_O\`30!I`&,`<@!O M`',`;P!F`'0`K@`@`$\`9@!F`&D`8P!E`"``5P!O`'(`9``@`#(`,``P`#)S5EDUK M'#$,AN^!_`?]@[$MR1\0TC#TTGR0;J#Y]WUM#4MH=AD=J!0H5F*EV*@$2A@&I10I"D:)8L&(<0,CP841KHI1)H[X63`Y MX"=QQ9U`HHF821H3"VEJQ(FT"'&F#"`7RCHRYE8(CTMG5JH!%`2!LE%%!A30 M8B:)U,"41*U6$D:!J`2R&')/A]B@RA0C,DE!S-!5BBE`UQ!!0HTQE4R*-^.( MBO!J#)&"QQ6%@B=X>P5/%#KPI/7**2K*0\E1,W3@992*U#'W5P(O%\`POX2> M%$Y63()G(0.>$>',U=6TZ:)`VVDW;::;.PK?:=K\).[WKJ\O+TY(XKHDK4MX M72+K$EV7Y'5)69?4=4ES6'?27GR@'S5QK!>/U=.^5K'T=D`OX%-()]W'%VN$ M_;?A;>S#DZG2(MR]W#\='T\WZ*K/&EM*'CV&=CAIY+^9Q]/>9.<*T',%E,\: M*Z`BB2=UMM3E7&J`%OUVZ(/IDP4]-^VX@OO['[_F45%;U=HG[F@F=G03>]K) MT4_L:"AV=!0[6HH=/<6.IF)'5XG#9W'X+`Z?Q;-O.7P6A\_B\%D&S.GS6TSX?MZ_YX3`VR]&V?7L<831FWR9'B!:LP9/M3$DLV+QD>T8J M%HS"2S"8&$P,)@83@XG!Q&!B,#&8&$6,HD91HZA1U"AJ%#6*&D6-HD91HV2C MY&5[7VS9O[_,T^[P^O9PV+_.\_;Y^3!M[E_GIS'L)\G88>\6A[NOQZ>W\Y_# MS?Q.<6'=OCW^QI^`?NH<4WRQRW8X?57X>-Z<"1_/A6/X7];X\N(O]L)$BPT* M96YD7!E+UA2968O4VEZ92`V M-2]76R`Q(#0@,ET@+U)O;W0@,2`P(%(O26YF;R`Q,2`P(%(O241;/#(P0T(P M,C-"-45%-D8P-$$Y,C`P13@T-T$W,38Q0D$U/CPR,$-",#(S0C5%139&,#1! M.3(P,$4X-#=!-S$V,4)!-3Y=("]&:6QT97(O1FQA=&5$96-O9&4O3&5N9W1H M(#$U.#X^#0IS=')E86T-"GB<-="W$<(`#(5AV61G&Y.Q"2;GO>CH&8F2EAF8 M@3FX,T8_J-!W.NE4/)&B\MPH>BCRY0IWQ;@I5@9/Q7XHSD5QSXJ7*GXD8NJS M`QQA#[_=J;@,S/]D@`DE*$,%JE"#.C3`@AB:X(`-/KC@000!A-""-G2@"SWH MPP"&D$`*(QC#!*:0P0SFL(`EK&`-&]C"KH@N>FG6<0)OD0]J01&4#0IE;F1S M=')E86T-"F5N9&]B:@T*>')E9@T*,"`V-@T*,#`P,#`P,#`Q,B`V-34S-2!F M#0HP,#`P,#`P,#$W(#`P,#`P(&X-"C`P,#`P,#`Q,C4@,#`P,#`@;@T*,#`P M,#`P,#$X,2`P,#`P,"!N#0HP,#`P,#`P-#(Y(#`P,#`P(&X-"C`P,#`P,#(U M.34@,#`P,#`@;@T*,#`P,#`P,C')E9@T*-S0W-@T*)25% "3T8_ ` end -----END PRIVACY-ENHANCED MESSAGE-----